Page last updated: 2024-10-29

itopride and Gastric Diseases

itopride has been researched along with Gastric Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Carbone, F1
Vandenberghe, A1
Holvoet, L1
Piessevaux, H1
Arts, J1
Caenepeel, P1
Staessen, D1
Vergauwe, P1
Maldague, P1
De Ronde, T1
Wuestenberghs, F1
Lamy, V1
Lefebvre, V1
Latour, P1
Vanuytsel, T1
Jones, M1
Tack, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Validation of a Questionnaire for Symptom Assessment in Postprandial Distress Syndrome (Functional Dyspepsia)[NCT04647955]Phase 4100 participants (Actual)Interventional2013-02-22Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for itopride and Gastric Diseases

ArticleYear
A double-blind randomized, multicenter, placebo-controlled study of itopride in functional dyspepsia postprandial distress syndrome.
    Neurogastroenterology and motility, 2022, Volume: 34, Issue:8

    Topics: Abdominal Pain; Benzamides; Benzyl Compounds; Dyspepsia; Female; Humans; Male; Postprandial Period;

2022